Prognosis
Moderna, U.S. Reach Deal for 100 Million Covid-19 Vaccine Doses
- Vaccine priced at $15 a dose in deal worth up to $1.5 billion
- U.S. already reached accords with Pfizer and BioNTech, J&J
This article is for subscribers only.
Moderna Inc. reached a deal with the Trump administration to supply 100 million doses of its experimental vaccine for Covid-19, in a pact valued at up to $1.5 billion, the latest in a string of supply agreements the U.S. has reached to stockpile the most advanced vaccines in testing.
“I’m pleased to announce we’ve reached an agreement with Moderna to manufacture and deliver 100 million doses of the coronavirus vaccine candidate,” President Donald Trump said at a White House briefing. “The federal government will own these vaccine doses, we’re buying them.”